SOFIE and GE HealthCare
Enter Licensing Agreement to
Develop FAP PET Radiotracers
VIEW THE PRESS RELEASE
Learn how our team is dedicated to making
a difference in patients' lives around the world.
Meet the people behind the science
See the employee spotlight
We are committed to the future of molecularly targeted therapeutics and companion diagnostics
Center of Excellence
Take a video tour
We are pleased to offer our academic community the use of FAPI as a diagnostic or companion diagnostic tool.
Be part of the FAPI Community
Find out more
With over 50 years of passion and dedication for the future of PET, we have taken bold steps to advance the development of next generation radiopharmaceuticals.
To improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value radiopharmaceutical intellectual property, we are poised to deliver on the promise of radiopharmaceuticals.